Hemostemix Inc HMTXF
Trading Information
- Previous Close Price
- $0.04
- Day Range
- $0.04–0.04
- 52-Week Range
- $0.04–0.09
- Bid/Ask
- $0.03 / $0.06
- Shares Outstanding
- 211.44M
- Market Cap
- $8.60M
- Volume/Avg
- 220 / 14,642
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Hemostemix Inc is a clinical-stage biotechnology company whose principal business is to develop, manufacture, and commercialize blood-derived stem cell therapies for medical conditions not adequately addressed by current treatments. Its product ACP-01 is derived from a patient's own blood and evaluated in clinical research for ischemic conditions, including Cardiovascular Ischemia, Peripheral Arterial Disease (PAD), Chronic Limb Threatening Ischemia (CLTI), and Vascular Dementia.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- https://www.hemostemix.com
Valuation
|
Metric
|
HMTXF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
HMTXF
Financial Strength
|
Metric
|
HMTXF
|
|---|---|
Quick Ratio | 0.13 |
Current Ratio | 0.13 |
Interest Coverage | −18.22 |
Quick Ratio
HMTXF
Profitability
|
Metric
|
HMTXF
|
|---|---|
Return on Assets (Normalized) | −734.51% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
HMTXF
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|lZ&ZrC$ | LOCK|!cHg | $128B | |||
| Moderna Inc
MRNA
| LOCK|$>k@v?C | LOCK|QF< | $81B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|zLjl<z | LOCK|G&F@Y | $75B | |||
| argenx SE ADR
ARGX
| LOCK|rxnTY<t | LOCK|$& | $57B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|?!#BLZ | LOCK|d>n | $43B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|zqCkdzY | LOCK|<q%p^ | $29B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|?<L&m%q | LOCK|<Z%> | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|nS@>v& | LOCK|ygt | $25B | |||
| Incyte Corp
INCY
| LOCK|>d>#dM | LOCK|@^> | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|MBKJ?Jh | LOCK|d^ | $15B |
United States